APA (7th ed.) Citation

Ahmadi, E., Ravanshad, M., Xie, J., Panigrahi, R., Jubbal, S. S., Guru, S. K., . . . Fingeroth, J. (2021). Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders. BMC.

Chicago Style (17th ed.) Citation

Ahmadi, Elham, Mehrdad Ravanshad, Jun Xie, Rajesh Panigrahi, Sandeep S. Jubbal, Santosh Kumar Guru, Gao Guangping, Mazyar Ziyaeyan, and Joyce Fingeroth. Serotype-dependent Recombinant Adeno-associated Vector (AAV) Infection of Epstein–Barr Virus-positive B-cells, Towards Recombinant AAV-based Therapy of Focal EBV + lymphoproliferative Disorders. BMC, 2021.

MLA (8th ed.) Citation

Ahmadi, Elham, et al. Serotype-dependent Recombinant Adeno-associated Vector (AAV) Infection of Epstein–Barr Virus-positive B-cells, Towards Recombinant AAV-based Therapy of Focal EBV + lymphoproliferative Disorders. BMC, 2021.